Response Rate After Modified Regime DHAP and Toxicity with Refractory and Relapsed Disease in Lymphoma Patients

Objective: To assess the response rate and toxicity of a modified regimen DHAP (dexamethasone, cytarabine, and cisplatin) and to compare treatment response and toxicity profile with disease status in patients with refractory and relapsed lymphoma who presented to a public hospital in Karachi, Paki...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Reeta Kumari, Ghullam Haider, Nargis Abro, Amera Shah, Tooba Sarim, Khadijah Abid
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	National University of Medical Sciences 2023-10-01
Edice:	Life and Science
Témata:	lymphoma, modified dhap, relapse lymphoma, refractory disease, toxicity
On-line přístup:	https://ojs.lifenscience.org/index.php/life-and-science/article/view/348
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!